{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"KeywordList": [["Activity", "Antimicrobial", "Biofilm", "Candida albicans", "Medicinal plant", "Toxicity"]], "SpaceFlightMission": [], "InvestigatorList": [], "OtherAbstract": [], "OtherID": [], "CitationSubset": ["IM"], "GeneralNote": [], "PMID": "28482836", "DateCompleted": {"Year": "2017", "Month": "08", "Day": "21"}, "DateRevised": {"Year": "2024", "Month": "05", "Day": "31"}, "Article": {"ArticleDate": [{"Year": "2017", "Month": "05", "Day": "08"}], "Language": ["eng"], "ELocationID": ["257", "10.1186/s12906-017-1760-x"], "Journal": {"ISSN": "1472-6882", "JournalIssue": {"Volume": "17", "Issue": "1", "PubDate": {"Year": "2017", "Month": "May", "Day": "08"}}, "Title": "BMC complementary and alternative medicine", "ISOAbbreviation": "BMC Complement Altern Med"}, "ArticleTitle": "Assessment of herbal drugs for promising anti-Candida activity.", "Pagination": {"StartPage": "257", "MedlinePgn": "257"}, "Abstract": {"AbstractText": ["Microbial infections are diverse and cause serious human diseases. Candida albicans infections are serious healthcare-related infections that are complicated by its morphological switching from yeast to hyphae, resistant biofilm formation and mixed infections with bacteria. Due to the increase in drug resistance to currently used antimicrobial agents and the presence of undesirable side effects, the need for safe and effective novel therapies is important. Compounds derived from plants are known for their medicinal properties including antimicrobial activities. The purpose of the study was to compare and evaluate the anti-Candida activities of several medicinal plants in order for the selection of a herbal drug for human use as effective antimicrobial. The selection was taking into considerations two important parameters; parameters related to the selected drug including activity, stability, solubility and toxicity and parameters related to the pathogen including its different dynamic growth and its accompanied secondary bacterial infections.", "Seven different plants including Avicennia marina (Qurm), Fagonia indica (Shoka'a), Lawsania inermis (Henna), Portulaca oleracea (Baq'lah), Salvadora persica (Souwak), Ziziphus spina- Christi (Sidr) and Asphodelus tenuifolius (Kufer) were ground and extracted with ethanol. The ethanol extracts were evaporated and the residual extract dissolved in water prior to testing against Candida albicans in its different morphologies. The antibacterial and cytotoxic effects of the plants extracts were also tested.", "Out of the seven tested plants, L. inermis and P. oleracea showed significant anti-Candida activity with MIC ~10\u00a0\u03bcg/mL. Furthermore, both plant extracts were able to inhibit C. albicans growth at its dynamic growth phases including biofilm formation and age resistance. Accompanied secondary bacterial infections can complicate Candida pathogenesis. L. inermis and P. oleracea extracts showed effective antibacterial activities against S. aureus, P. aeruginosa, E. coli, and the multidrug resistant (MDR) A. baumannii and Klebsiella pneumoniae. Both extracts showed no toxicity when measured at their MIC on human erythrocytes.", "The results from this study suggested that L. inermis and P. oleracea extracts and/or their chemicals are likely to be promising drugs for human use against C. albicans and MDR bacteria."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Medicinal Chemistry, College of Pharmacy, University of Sharjah, Sharjah, PO Box 27272, United Arab Emirates. ssoliman@sharjah.ac.ae."}, {"Identifier": [], "Affiliation": "Sharjah Institute for Medical Research, University of Sharjah, Sharjah, United Arab Emirates. ssoliman@sharjah.ac.ae."}, {"Identifier": [], "Affiliation": "Permanent address: Department of Pharmacognosy, Faculty of Pharmacy, University of Zagazig, Zagazig, Egypt. ssoliman@sharjah.ac.ae."}], "LastName": "Soliman", "ForeName": "Sameh S M", "Initials": "SSM"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Medicinal Chemistry, College of Pharmacy, University of Sharjah, Sharjah, PO Box 27272, United Arab Emirates."}, {"Identifier": [], "Affiliation": "Sharjah Institute for Medical Research, University of Sharjah, Sharjah, United Arab Emirates."}], "LastName": "Semreen", "ForeName": "Mohammad H", "Initials": "MH"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Applied Biology, University of Sharjah, Sharjah, United Arab Emirates."}], "LastName": "El-Keblawy", "ForeName": "Ali A", "Initials": "AA"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "University Hospital Sharjah, Sharjah, United Arab Emirates."}], "LastName": "Abdullah", "ForeName": "Arbab", "Initials": "A"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Division of Infectious Diseases, Los Angeles Biomedical Research Institute, Harbor-UCLA Medical Center, Torrance, CA, USA."}, {"Identifier": [], "Affiliation": "David Geffen School of Medicine at UCLA, Los Angeles, CA, USA."}], "LastName": "Uppuluri", "ForeName": "Priya", "Initials": "P"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Division of Infectious Diseases, Los Angeles Biomedical Research Institute, Harbor-UCLA Medical Center, Torrance, CA, USA."}, {"Identifier": [], "Affiliation": "David Geffen School of Medicine at UCLA, Los Angeles, CA, USA."}], "LastName": "Ibrahim", "ForeName": "Ashraf S", "Initials": "AS"}], "GrantList": [{"GrantID": "R01 AI063503", "Acronym": "AI", "Agency": "NIAID NIH HHS", "Country": "United States"}, {"GrantID": "UL1 TR000124", "Acronym": "TR", "Agency": "NCATS NIH HHS", "Country": "United States"}, {"GrantID": "UL1 TR001881", "Acronym": "TR", "Agency": "NCATS NIH HHS", "Country": "United States"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "England", "MedlineTA": "BMC Complement Altern Med", "NlmUniqueID": "101088661", "ISSNLinking": "1472-6882"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Anti-Bacterial Agents"}, {"RegistryNumber": "0", "NameOfSubstance": "Antifungal Agents"}, {"RegistryNumber": "0", "NameOfSubstance": "Plant Extracts"}], "MeshHeadingList": [{"QualifierName": ["chemistry", "pharmacology"], "DescriptorName": "Anti-Bacterial Agents"}, {"QualifierName": ["chemistry", "pharmacology"], "DescriptorName": "Antifungal Agents"}, {"QualifierName": ["drug effects", "growth & development"], "DescriptorName": "Bacteria"}, {"QualifierName": ["drug effects", "growth & development"], "DescriptorName": "Candida"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": [], "DescriptorName": "Microbial Sensitivity Tests"}, {"QualifierName": ["chemistry", "metabolism"], "DescriptorName": "Plant Extracts"}, {"QualifierName": ["chemistry"], "DescriptorName": "Plants, Medicinal"}]}, "PubmedData": {"ReferenceList": [{"ReferenceList": [], "Reference": [{"Citation": "Inghammar M, Engstr\u00f6m G, Ljungberg B, L\u00f6fdahl C-G, Roth A, Egesten A. Increased incidence of invasive bacterial disease in chronic obstructive pulmonary disease compared to the general population-a population based cohort study. BMC Infect Dis. 2014;14(1):163. doi: 10.1186/1471-2334-14-163.", "ArticleIdList": ["10.1186/1471-2334-14-163", "PMC3976148", "24661335"]}, {"Citation": "Spellberg B, Guidos R, Gilbert D, Bradley J, Boucher HW, Scheld WM, Bartlett JG, Edwards J. America tIDSo. The epidemic of antibiotic-resistant infections: A call to action for the medical community from the infectious diseases society of America. Clin Infect Dis. 2008;46(2):155\u2013164. doi: 10.1086/524891.", "ArticleIdList": ["10.1086/524891", "18171244"]}, {"Citation": "Ventola CL. The antibiotic resistance crisis: Part 1: Causes and threats. Pharm Ther. 2015;40(4):277\u2013283.", "ArticleIdList": ["PMC4378521", "25859123"]}, {"Citation": "Poulin M-C, Villeneuve J. Drug Shortages: A public health issue that demands a coordinated response. Recommendations of the working committee on drug shortages. Qu\u00e9bec: Ordre des pharmaciens du Qu\u00e9bec; 2012."}, {"Citation": "Dancer SJ. How antibiotics can make us sick: the less obvious adverse effects of antimicrobial chemotherapy. Lancet Infect Dis. 2004;4:611\u2013619. doi: 10.1016/S1473-3099(04)01145-4.", "ArticleIdList": ["10.1016/S1473-3099(04)01145-4", "15451489"]}, {"Citation": "Stefano D, Paolo M, Marianna I, Sonia M, Margherita S. Discovering new bioactive molecules from microbial sources. Microb Biotechnol. 2014;7(3):209\u2013220. doi: 10.1111/1751-7915.12123.", "ArticleIdList": ["10.1111/1751-7915.12123", "PMC3992017", "24661414"]}, {"Citation": "White TC, Marr KA, Bowden RA. Clinical, cellular, and molecular factors that contribute to antifungal drug resistance. Clin Microbiol Rev. 1998;11(2):382\u2013402.", "ArticleIdList": ["PMC106838", "9564569"]}, {"Citation": "d\u2019Enfert C. Hidden killers: Persistence of opportunistic fungal pathogens in the human host. Curr Opin Microbiol. 2009;12(4):358\u2013364. doi: 10.1016/j.mib.2009.05.008.", "ArticleIdList": ["10.1016/j.mib.2009.05.008", "19541532"]}, {"Citation": "Rees JR, Pinner RW, Hajjeh RA, Brandt ME, Reingold AL. The epidemiological features of invasive mycotic infections in the San Francisco bay area, 1992\u20131993: Results of population-based laboratory active surveillance. Clin Infect Dis. 1998;27(5):1138\u20131147. doi: 10.1093/clinids/27.5.1138.", "ArticleIdList": ["10.1093/clinids/27.5.1138", "9827260"]}, {"Citation": "Vazquez JA, Sanchez V, Dmuchowski C, Dembry LM, Sobel JD, Zervos MJ. Nosocomial acquisition of Candida albicans: An epidemiologic study. J Infect Dis. 1993;168(1):195\u2013201. doi: 10.1093/infdis/168.1.195.", "ArticleIdList": ["10.1093/infdis/168.1.195", "8515108"]}, {"Citation": "Wisplinghoff H, Bischoff T, Tallent SM, Seifert H, Wenzel RP, Edmond MB. Nosocomial bloodstream infections in US hospitals: Analysis of 24,179 cases from a prospective nationwide surveillance study. Clin Infect Dis. 2004;39(3):309\u2013317. doi: 10.1086/421946.", "ArticleIdList": ["10.1086/421946", "15306996"]}, {"Citation": "Trick WE, Fridkin SK, Edwards JR, Hajjeh RA, Gaynes RP. Secular trend of hospital-acquired candidemia among intensive care unit patients in the united states during 1989\u20131999. Clin Infect Dis. 2002;35(5):627\u2013630. doi: 10.1086/342300.", "ArticleIdList": ["10.1086/342300", "12173140"]}, {"Citation": "Mukherjee PK, Chandra J. Candida biofilm resistance. Drug Resist Updat. 2004;7(4):301\u2013309. doi: 10.1016/j.drup.2004.09.002.", "ArticleIdList": ["10.1016/j.drup.2004.09.002", "15533767"]}, {"Citation": "Brand A. Hyphal growth in human fungal pathogens and its role in virulence. Int J Microbiol. 2012;2012:1\u201311. doi: 10.1155/2012/517529.", "ArticleIdList": ["10.1155/2012/517529", "PMC3216317", "22121367"]}, {"Citation": "Kojic EM, Darouiche RO. Candida infections of medical devices. Clin Microbiol Rev. 2004;17(2):255\u2013267. doi: 10.1128/CMR.17.2.255-267.2004.", "ArticleIdList": ["10.1128/CMR.17.2.255-267.2004", "PMC387407", "15084500"]}, {"Citation": "Rodney MD. Biofilms and device-associated infections. Emerg Infect Dis J. 2001;7(2):277. doi: 10.3201/eid0702.010226.", "ArticleIdList": ["10.3201/eid0702.010226", "PMC2631701", "11294723"]}, {"Citation": "DiDone L, Oga D, Krysan DJ. A novel assay of biofilm antifungal activity reveals that amphotericin B and caspofungin lyse Candida albicans cells in biofilms. Yeast. 2011;28(8):561\u2013568. doi: 10.1002/yea.1860.", "ArticleIdList": ["10.1002/yea.1860", "21674619"]}, {"Citation": "Humber JM. The role of complementary and alternative medicine: accommodating pluralism. JAMA. 2002;288(13):1655\u20131656. doi: 10.1001/jama.288.13.1655.", "ArticleIdList": ["10.1001/jama.288.13.1655"]}, {"Citation": "Bishop FL, Lewith G. Who uses CAM? A narrative review of demographic characteristics and health factors associated with CAM use. Evid Based Complement Alternat Med. 2010;7(1):11\u201328. doi: 10.1093/ecam/nen023.", "ArticleIdList": ["10.1093/ecam/nen023", "PMC2816378", "18955327"]}, {"Citation": "Ebrahimy F, Dolatian M, Moatar F, Majd HA. Comparison of the therapeutic effects of Garcin\u00ae and fluconazole on Candida vaginitis. Singap Med J. 2015;56(10):567\u2013572. doi: 10.11622/smedj.2015153.", "ArticleIdList": ["10.11622/smedj.2015153", "PMC4613933", "26512149"]}, {"Citation": "Varadarajan S, Narasimhan M, Malaisamy M, Duraipandian C. Invitro anti-mycotic activity of hydro alcoholic extracts of some indian medicinal plants against fluconazole resistant Candida albicans. J Clin Diagn Res. 2015;9(8):ZC07\u2013ZC10.", "ArticleIdList": ["PMC4576630", "26436036"]}, {"Citation": "Dhamgaye S, Devaux F, Vandeputte P, Khandelwal NK, Sanglard D, Mukhopadhyay G, Prasad R. Molecular mechanisms of action of herbal antifungal alkaloid berberine, in Candida albicans. PLoS One. 2014;9(8):e104554. doi: 10.1371/journal.pone.0104554.", "ArticleIdList": ["10.1371/journal.pone.0104554", "PMC4126717", "25105295"]}, {"Citation": "Liu X, Han Y, Peng K, Liu Y, Li J, Liu H. Effect of traditional chinese medicinal herbs on Candida spp. From patients withHIV/AIDS. Adv Dent Res. 2011;23(1):56\u201360. doi: 10.1177/0022034511399286.", "ArticleIdList": ["10.1177/0022034511399286", "21441482"]}, {"Citation": "Soares IH, Loreto \u00c9S, Rossato L, Mario DN, Venturini TP, Baldissera F, Santurio JM, Alves SH. In vitro activity of essential oils extracted from condiments against fluconazole-resistant and -sensitive Candida glabrata. J Med Mycol. 2015;25(3):213\u2013217. doi: 10.1016/j.mycmed.2015.06.003.", "ArticleIdList": ["10.1016/j.mycmed.2015.06.003", "26281965"]}, {"Citation": "Haba E, Bouhdid S, Torrego-Solana N, Marqu\u00e9s AM, Espuny MJ, Garc\u00eda-Celma MJ, Manresa A. Rhamnolipids as emulsifying agents for essential oil formulations: Antimicrobial effect against Candida albicans and methicillin-resistant Staphylococcus aureus. Int J Pharm. 2014;476(1\u20132):134\u2013141. doi: 10.1016/j.ijpharm.2014.09.039.", "ArticleIdList": ["10.1016/j.ijpharm.2014.09.039", "25269010"]}, {"Citation": "Vale-Silva L, Silva M-J, Oliveira D, Gon\u00e7alves M-J, Cavaleiro C, Salgueiro L, Pinto E. Correlation of the chemical composition of essential oils from Origanum vulgare subsp. virens with their in vitro activity against pathogenic yeasts and filamentous fungi. J Med Microbiol. 2012;61(2):252\u2013260. doi: 10.1099/jmm.0.036988-0.", "ArticleIdList": ["10.1099/jmm.0.036988-0", "22016556"]}, {"Citation": "Authority H. Encyclopedia of Medicinal Plants of UAE. Abu Dhabi: Zayed Center for Herbal Research. Zayed Complex for Herbal Research and Traditional Medicine (ZCHRTM); 2005."}, {"Citation": "Mahasneh AM. Screening of some indigenous Qatari medicinal plants for antimicrobial activity. Phytother Res. 2002;16(8):751\u2013753. doi: 10.1002/ptr.1037.", "ArticleIdList": ["10.1002/ptr.1037", "12458480"]}, {"Citation": "Singh VK, Pandey DK. Fungitoxic studies on bark extract of Lawsonia inermis against ringworm fungi. Hindustan Antibiot Bull. 1989;31(1\u20132):32\u201335.", "ArticleIdList": ["2613539"]}, {"Citation": "Oh K-B, Chang I-M, Hwang K-J, Mar W. Detection of antifungal activity in Portulaca oleracea by a single-cell bioassay system. Phytother Res. 2000;14(5):329\u2013332. doi: 10.1002/1099-1573(200008)14:5<329::AID-PTR581>3.0.CO;2-5.", "ArticleIdList": ["10.1002/1099-1573(200008)14:5<329::AID-PTR581>3.0.CO;2-5", "10925396"]}, {"Citation": "Halawany HS. A review on miswak (Salvadora persica) and its effect on various aspects of oral health. Saudi Dent J. 2012;24(2):63\u201369. doi: 10.1016/j.sdentj.2011.12.004.", "ArticleIdList": ["10.1016/j.sdentj.2011.12.004", "PMC3723367", "23960531"]}, {"Citation": "Ezoddini-Ardakani F. Efficacy of miswak (Salvadora persica) in preventing dental caries. Health (N Y) 2010;2:499\u2013503."}, {"Citation": "Naseem S, Hashmi K, Fasih F, Sharafat S, Khanani R. In vitro evaluation of antimicrobial effect of miswak against common oral pathogens. Pak J Med Sci. 2014;30(2):398\u2013403. doi: 10.12669/pjms.302.4284.", "ArticleIdList": ["10.12669/pjms.302.4284", "PMC3999018", "24772151"]}, {"Citation": "Shahat AA, Pieters L, Apers S, Nazeif NM, Abdel-Azim NS, Berghe DV, Vlietinck AJ. Chemical and biological investigations on Zizyphus spina-christi L. Phytother Res. 2001;15(7):593\u2013597. doi: 10.1002/ptr.883.", "ArticleIdList": ["10.1002/ptr.883", "11746840"]}, {"Citation": "Kirkpatrick WR, McAtee RK, Revankar SG, Fothergill AW, McCarthy DI, Rinaldi MG, Patterson TF. Comparative evaluation of national committee for clinical laboratory standards broth macrodilution and agar dilution screening methods for testing fluconazole susceptibility of Cryptococcus neoformans. J Clin Microbiol. 1998;36(5):1330\u20131332.", "ArticleIdList": ["PMC104822", "9574699"]}, {"Citation": "European Committee for Antimicrobial Susceptibility Testing of the European Society of Clinical M, Infectious D Determination of minimum inhibitory concentrations (MICs) of antibacterial agents by broth dilution. Clin Microbiol Infect. 2003;9(8):ix\u2013xv. doi: 10.1046/j.1469-0691.2003.00790.x.", "ArticleIdList": ["10.1046/j.1469-0691.2003.00790.x", "0"]}, {"Citation": "Eloff JN. Quantification the bioactivity of plant extracts during screening and bioassay guided fractionation. Phytomedicine. 2004;11(4):370\u2013371. doi: 10.1078/0944711041495218.", "ArticleIdList": ["10.1078/0944711041495218", "15185853"]}, {"Citation": "Espinel-Ingroff A, Fothergill A, Peter J, Rinaldi MG, Walsh TJ. Testing conditions for determination of minimum fungicidal concentrations of new and established antifungal agents for Aspergillus spp.: NCCLS collaborative study. J Clin Microbiol. 2002;40(9):3204\u20133208. doi: 10.1128/JCM.40.9.3204-3208.2002.", "ArticleIdList": ["10.1128/JCM.40.9.3204-3208.2002", "PMC130733", "12202554"]}, {"Citation": "Pierce CG, Uppuluri P, Tristan AR, Wormley FL, Mowat E, Ramage G, Lopez-Ribot JL. A simple and reproducible 96-well plate-based method for the formation of fungal biofilms and its application to antifungal susceptibility testing. Nat Protoc. 2008;3(9):1494\u20131500. doi: 10.1038/nprot.2008.141.", "ArticleIdList": ["10.1038/nprot.2008.141", "PMC2741160", "18772877"]}, {"Citation": "Nuryastuti T, van der Mei HC, Busscher HJ, Iravati S, Aman AT, Krom BP. Effect of cinnamon oil on icaa expression and biofilm formation by Staphylococcus epidermidis. Appl Environ Microbiol. 2009;75(21):6850\u20136855. doi: 10.1128/AEM.00875-09.", "ArticleIdList": ["10.1128/AEM.00875-09", "PMC2772433", "19749058"]}, {"Citation": "Bokori-Brown M, Martin TG, Naylor CE, Basak AK, Titball RW, Savva CG. Cryo-EM structure of lysenin pore elucidates membrane insertion by an aerolysin family protein. Nat Commun. 2016;7:11293. doi: 10.1038/ncomms11293.", "ArticleIdList": ["10.1038/ncomms11293", "PMC4823867", "27048994"]}, {"Citation": "Stark M, Liu L-P, Deber CM. Cationic hydrophobic peptides with antimicrobial activity. Antimicrob Agents Chemother. 2002;46(11):3585\u20133590. doi: 10.1128/AAC.46.11.3585-3590.2002.", "ArticleIdList": ["10.1128/AAC.46.11.3585-3590.2002", "PMC128737", "12384369"]}, {"Citation": "Bagla VP, McGaw LJ, Elgorashi EE, Eloff JN. Antimicrobial activity, toxicity and selectivity index of two biflavonoids and a flavone isolated from Podocarpus henkelii (Podocarpaceae) leaves. BMC Complement Altern Med. 2014;14:383. doi: 10.1186/1472-6882-14-383.", "ArticleIdList": ["10.1186/1472-6882-14-383", "PMC4197215", "25293523"]}, {"Citation": "Serrano-Fujarte I, Lopez-Romero E, Reyna-Lopez GE, Martinez-Gamez MA, Vega-Gonzalez A, Cuellar-Cruz M. Influence of culture media on biofilm formation by Candida species and response of sessile cells to antifungals and oxidative stress. Biomed Res Int. 2015;2015:15. doi: 10.1155/2015/783639.", "ArticleIdList": ["10.1155/2015/783639", "PMC4331161", "25705688"]}, {"Citation": "O\u2019Connor L, Caplice N, Coleman DC, Sullivan DJ, Moran GP. Differential filamentation of Candida albicans and Candida dubliniensis is governed by nutrient regulation of UME6 expression. Eukaryot Cell. 2010;9(9):1383\u20131397. doi: 10.1128/EC.00042-10.", "ArticleIdList": ["10.1128/EC.00042-10", "PMC2937345", "20639413"]}, {"Citation": "Loeb JDJ, Sepulveda-Becerra M, Hazan I, Liu H. A G(1) cyclin is necessary for maintenance of filamentous growth in Candida albicans. Mol Cell Biol. 1999;19(6):4019\u20134027. doi: 10.1128/MCB.19.6.4019.", "ArticleIdList": ["10.1128/MCB.19.6.4019", "PMC104361", "10330142"]}, {"Citation": "Ahn Y-J, Sakanaka S, Kim M-J, Kawamura T, Fujisawa T, Mitsuoka T. Effect of green tea extract on growth of intestinal bacteria. Microb Ecol Health Dis. 1990;3(6):335-8."}, {"Citation": "Muter O, Versilovskis A, Scherbaka R, Grube M, Zarina D. Effect of plant extract on the degradation of nitroaromatic compounds by soil microorganisms. J Ind Microbiol Biotechnol. 2008;35(11):1539\u20131543. doi: 10.1007/s10295-008-0455-1.", "ArticleIdList": ["10.1007/s10295-008-0455-1", "18712534"]}, {"Citation": "Sudbery P, Gow N, Berman J. The distinct morphogenic states of Candida albicans. Trends Microbiol. 2004;12(7):317\u2013324. doi: 10.1016/j.tim.2004.05.008.", "ArticleIdList": ["10.1016/j.tim.2004.05.008", "15223059"]}, {"Citation": "Sudbery PE. Growth of Candida albicans hyphae. Nat Rev Microbiol. 2011;9(10):737\u2013748. doi: 10.1038/nrmicro2636.", "ArticleIdList": ["10.1038/nrmicro2636", "21844880"]}, {"Citation": "Filler SG, Sheppard DC. Fungal invasion of normally non-phagocytic host cells. PLoS Pathog. 2006;2(12):e129. doi: 10.1371/journal.ppat.0020129.", "ArticleIdList": ["10.1371/journal.ppat.0020129", "PMC1757199", "17196036"]}, {"Citation": "Chen H, Fujita M, Feng Q, Clardy J, Fink GR. Tyrosol is a quorum-sensing molecule in Candida albicans. Proc Natl Acad Sci U S A. 2004;101(14):5048\u20135052. doi: 10.1073/pnas.0401416101.", "ArticleIdList": ["10.1073/pnas.0401416101", "PMC387371", "15051880"]}, {"Citation": "De Sordi L, M\u00fchlschlegel FA. Quorum sensing and fungal\u2013bacterial interactions in Candida albicans: A communicative network regulating microbial coexistence and virulence. FEMS Yeast Res. 2009;9(7):990\u2013999. doi: 10.1111/j.1567-1364.2009.00573.x.", "ArticleIdList": ["10.1111/j.1567-1364.2009.00573.x", "19845041"]}, {"Citation": "Jenkinson H, Douglas L. Interactions between Candida Species and bacteria in mixed infections. In: Brogden KA, Guthmiller JM, editors. Polymicrobial Diseases. edn. Washington (DC): ASM Press; 2002.", "ArticleIdList": ["21735561"]}, {"Citation": "Johnson B, White RJ, Williamson GM. Factors influencing the susceptibility of Candida albicans to the polyenoic antibiotics nystatin and amphotericin B. J Gen Microbiol. 1987;104:325\u2013333. doi: 10.1099/00221287-104-2-325.", "ArticleIdList": ["10.1099/00221287-104-2-325", "24676"]}, {"Citation": "Hammond SM, Kliger BN. Mode of action of the polyene antibiotic candicidin: binding factors in the wall of Candida albicans. Antimicrob Agents Chemother. 1976;9(4):561\u2013568. doi: 10.1128/AAC.9.4.561.", "ArticleIdList": ["10.1128/AAC.9.4.561", "PMC429577", "773298"]}, {"Citation": "Hammond SM, Kliger BN. Studies on the role of the cell wall of Candida albicans in the mode of action of polyene antibiotics. Proc Soc Gen Microbiol. 1974;1:45."}, {"Citation": "Gale EF. The release of potassium ions from Candida albicans in the presence of polyene antibiotics. J Gen Microbiol. 1974;80:451\u2013465. doi: 10.1099/00221287-80-2-451.", "ArticleIdList": ["10.1099/00221287-80-2-451", "4596987"]}, {"Citation": "Westwater C, Balish E, Schofield DA. Candida albicans-conditioned medium protects yeast cells from oxidative stress: A possible link between quorum sensing and oxidative stress resistance. Eukaryot Cell. 2005;4(10):1654\u20131661. doi: 10.1128/EC.4.10.1654-1661.2005.", "ArticleIdList": ["10.1128/EC.4.10.1654-1661.2005", "PMC1265892", "16215173"]}, {"Citation": "Bailie G, Kane M. Stability of drug additives to peritoneal dialysate. Perit Dial Int. 1995;15(8):328\u2013335.", "ArticleIdList": ["8785230"]}, {"Citation": "Arya SC, Agarwal N. Antimicrobial storage and antibiotic resistance. J Am Board Fam Med. 2008;21(2):168. doi: 10.3122/jabfm.2008.02.070233.", "ArticleIdList": ["10.3122/jabfm.2008.02.070233", "18343869"]}, {"Citation": "Juvvadi P, Vunnam S, Merrifield RB. Synthetic melittin, its enantio, retro, and retroenantio isomers, and selected chimeric analogs: their antibacterial, hemolytic, and lipid bilayer action. J Am Chem Soc. 1996;118(38):8989\u20138997. doi: 10.1021/ja9542911.", "ArticleIdList": ["10.1021/ja9542911"]}]}], "History": [{"Year": "2017", "Month": "1", "Day": "13"}, {"Year": "2017", "Month": "4", "Day": "28"}, {"Year": "2017", "Month": "5", "Day": "10", "Hour": "6", "Minute": "0"}, {"Year": "2017", "Month": "5", "Day": "10", "Hour": "6", "Minute": "0"}, {"Year": "2017", "Month": "8", "Day": "22", "Hour": "6", "Minute": "0"}, {"Year": "2017", "Month": "5", "Day": "8"}], "PublicationStatus": "epublish", "ArticleIdList": ["28482836", "PMC5422888", "10.1186/s12906-017-1760-x", "10.1186/s12906-017-1760-x"]}}]}